following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..

the latest figures mean that since january 2000, scottish widows has paid a total of £2.5bn in claims to more than 86,000 customers.. september 2009  (17).
it also provides 85 per cent accurate prediction results than current methods...

eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention... august 2015  (25).

copyright © 2018 the indian express [p] ltd. all rights reserved